Abbott Laboratories (ABT) Stock Price
Abbott Laboratories Price
Abbott Laboratories (ABT) Stock | ISIN US0028241000 | WKN 850103. The current Abbott Laboratories stock price is 88.79 USD (2026). Revenue is 48.27 B USD. Net income is 10.04 B USD. The P/E ratio is 15.46. Market capitalization is 155.2 B USD. Abbott Laboratories operates in the Health sector.
Over the last 19 years Abbott Laboratories grew revenue by 3.6% annually, reaching 44.33 B USD. Earnings per share have grown at 6.6% per year over the last 19 years. For Abbott Laboratories, the net margin of 14.7% is down versus 16.4% a few years ago. At today's price the dividend yield works out to roughly 2.66%. The payout ratio is around 49% of earnings. The dividend has grown at 3.8% per year over the past 19 years.
Abbott Laboratories stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Abbott Laboratories over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Abbott Laboratories stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Abbott Laboratories's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Abbott Laboratories Price |
|---|
Abbott Laboratories Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Abbott Laboratories Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (B USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (B USD) |
| NET INCOME (B USD) |
| NET INCOME GROWTH (%) |
| DIVIDEND (USD)DIV. (USD) |
| DIVIDEND GROWTH (%)DIV. GROWTH (%) |
| SHARES (B) |
| DOCUMENTS |
| 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | 2030e | 2031e |
|---|---|---|---|---|---|---|---|
| 41.95 | 44.33 | 48.27 | 51.84 | 55.48 | 59.18 | 63.47 | 67.63 |
| 4.59 | 5.67 | 8.9 | 7.39 | 7.02 | 6.67 | 7.25 | 6.55 |
| 55.56 | 56.66 | 52.03 | 48.45 | 45.27 | 42.44 | 39.57 | 37.14 |
| 23.31 | 25.12 | 25.12 | 25.12 | 25.12 | 25.12 | 25.12 | 25.12 |
| 13.4 | 6.52 | 10.04 | 11.04 | 12.09 | 12.98 | 14.75 | 16.07 |
| 134.18 | -51.32 | 53.89 | 9.99 | 9.5 | 7.34 | 13.67 | 8.89 |
| 2.2 | 2.36 | 2.52 | 3.06 | 3.37 | - | - | - |
| 7.84 | 7.27 | 6.78 | 21.43 | 10.13 | – | – | – |
| 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 |
| – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Abbott Laboratories generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Abbott Laboratories retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Abbott Laboratories's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Abbott Laboratories has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Abbott Laboratories's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Abbott Laboratories stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Abbott Laboratories Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Abbott Laboratories business model & stock analysis
Abbott Laboratories SWOT Analysis
Strengths
Abbott Laboratories possesses several key strengths that contribute to its success in the healthcare industry. These include:
- Strong Market Presence: As a well-established global healthcare company, Abbott Laboratories has a wide market reach and a strong brand reputation.
- Diversified Product Portfolio: With a diverse range of healthcare products, including pharmaceuticals, diagnostics, medical devices, and nutrition, Abbott Laboratories reduces its dependence on a single product or market segment.
- Innovation and R&D Capabilities: The company invests significantly in research and development to drive innovation and maintain a competitive edge in introducing new products and technologies.
- Financial Stability: Abbott Laboratories has a solid financial position, reflected in its consistent revenue growth and strong profitability, allowing the company to invest in expansion and acquisitions.
Weaknesses
Despite its strengths, Abbott Laboratories is also faced with certain weaknesses that could hinder its performance. These weaknesses include:
- Product Recalls and Quality Control Issues: The company has experienced occasional product recalls and quality control challenges, which can damage its reputation and consumer trust.
- Dependence on Third-Party Suppliers: Abbott Laboratories relies on a network of suppliers for raw materials and components, making it vulnerable to potential disruptions, such as supply chain issues or changes in supplier relationships.
- Regulatory Challenges: Operating in a highly regulated industry, Abbott Laboratories faces compliance challenges and increased scrutiny from regulatory authorities, which could impact its operations and product approvals.
Opportunities
Abbott Laboratories can explore various opportunities to further enhance its market position and growth potential, such as:
- Emerging Markets: Expanding into emerging markets, where there is a growing demand for healthcare products and services, presents significant opportunities for Abbott Laboratories to increase its customer base.
- Technological Advancements: Investing in advanced technologies and digital health solutions can help Abbott Laboratories stay ahead in the evolving healthcare landscape and provide innovative solutions to meet changing customer needs.
- Aging Population and Chronic Diseases: With the global rise in aging population and prevalence of chronic diseases, the demand for Abbott Laboratories' healthcare products and solutions is likely to increase, creating new market opportunities.
Threats
Abbott Laboratories needs to be aware of the following threats that could potentially impact its business negatively:
- Intense Competition: The healthcare industry is highly competitive, with numerous local and global players. Abbott Laboratories faces the risk of losing market share to competitors who offer similar healthcare products and solutions.
- Regulatory and Legal Risks: Compliance with rigorous regulations and potential legal challenges, including product liability claims, pose threats to Abbott Laboratories, requiring proactive risk management and legal expertise.
- Increasing Healthcare Costs: As healthcare costs continue to rise, governments and healthcare providers may exert pressure to reduce pricing, which could impact Abbott Laboratories' profitability.
Abbott Laboratories Eulerpool Fair Value
Abbott Laboratories historical P/E ratio, EBIT multiple, and P/S ratio
Abbott Laboratories annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Abbott Laboratories shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Abbott Laboratories Dividend History
37 years of dividend payments · 5 consecutive increases
Abbott Laboratories dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
Abbott Laboratories dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Abbott Laboratories Earnings Calls
Abbott Laboratories Earnings Estimates
Abbott Laboratories Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 4/14/2026 | 1.16USD | 11.1 BUSD | 2026 Q1 |
| 1/22/2026 | 1.51USD | 11.92 BUSD | 2025 Q4 |
| 1/20/2026 | 1.51USD | 11.92 BUSD | 2025 Q4 |
| 4/17/2024 | 1.05USD | 9.91 BUSD | 2024 Q1 |
| 1/23/2024 | 1.2USD | 10.28 BUSD | 2023 Q4 |
| 7/18/2023 | 1.1USD | 9.99 BUSD | 2023 Q2 |
| 4/18/2023 | 1.01USD | 9.55 BUSD | 2023 Q1 |
| 1/24/2023 | 0.92USD | 9.78 BUSD | 2022 Q4 |
| 10/19/2022 | 0.95USD | 9.82 BUSD | 2022 Q3 |
| 7/20/2022 | 1.14USD | 10.47 BUSD | 2022 Q2 |
EESG©
Eulerpool ESG Scorecard© for the Abbott Laboratories stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Abbott Laboratories shareholder structure
| % | Name |
|---|---|
9.99626% | |
5.31068% | |
4.56829% | |
3.61725% | |
2.2408% | |
2.19723% | |
1.34192% | |
1.34066% | |
1.02329% | |
0.89963% |
Abbott Laboratories Executives and Management Board
Mr. Robert Ford
(51)Chairman of the Board, Chief Executive Officer · since 2014
Mr. Philip Boudreau
(52)Chief Financial Officer, Executive Vice President - Finance
Mr. Hubert Allen
(59)Executive Vice President, General Counsel, Secretary
Ms. Lisa Earnhardt
(55)Executive Vice President, Group President - Medical Devices
Ms. Andrea Wainer
(56)Executive Vice President - Rapid and Molecular Diagnostics
Abbott Laboratories Supply Chain
Frequently asked questions about Abbott Laboratories
Abbott Laboratories is a renowned healthcare company with a strong business model focused on providing a diverse range of medical products, diagnostics, nutritional supplements, and pharmaceuticals. By combining technological advancements with innovative research, Abbott aims to enhance the quality of life for individuals worldwide. With a comprehensive portfolio spanning diverse healthcare sectors, including diagnostics, nutrition, diabetes care, medical devices, and branded generic pharmaceuticals, Abbott Laboratories strives to improve patient outcomes and deliver sustainable growth. Through its commitment to scientific excellence and dedication to meeting evolving healthcare needs, Abbott Laboratories has established itself as a trusted leader in the global healthcare industry.
Abbott Laboratories stock
Abbott Laboratories Peer Group
Abbott Laboratories Ticker
Abbott Laboratories FIGI
All fundamentals and in-depth analysis of Abbott Laboratories
Our stock analysis for Abbott Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Abbott Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.